The global veterinary vaccines market is projected to reach USD 8.66 Billion by 2022 from USD 6.50 Billion in 2017, at a CAGR of 5.9% during the forecast period (2017-2022).
The major factors driving the growth of this market include growth in livestock population and repeated breakouts of livestock diseases; increasing adoption of companion animals; rising incidence of zoonotic diseases; initiatives by various government agencies, animal associations, and leading players; and the introduction of new types of vaccines.
In 2017, in terms of value, Europe is expected to account for the largest share of the global animal vaccines market, followed by North America. However, the Asia Pacific region is expected to register the highest growth during the forecast period. Rising pet adoption, expansion of key players in the region, a wide range of product launches, and investments in vaccine manufacturing facilities, especially in India, China, and Thailand, are driving the growth of this regional segment.
The key players in the veterinary vaccines market include Zoetis (US), Merck Animal Health (US), Elanco Animal Health (US), Boehringer Ingelheim (Germany), Ceva (France), Phibro Animal Health (US), and Virbac (France).
Key Topics Covered:
1 Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Markets Covered 1.3.2 Years Considered for the Study 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2 Research Methodology 2.1 Research Data 2.1.1 Secondary Data 188.8.131.52 Key Data from Secondary Sources 2.1.2 Primary Data 184.108.40.206 Key Data from Primary Sources 220.127.116.11 Breakdown of Primary Interviews 18.104.22.168 Key Industry Insights 2.2 Market Size Estimation 2.3 Market Breakdown And Data Triangulation 2.3.1 Research Assumptions
3 Executive Summary
4 Premium Insights 4.1 Global Veterinary Vaccines Market Overview 4.2 Apac Veterinary Vaccines Market, By Technology And Region 4.3 Poultry Veterinary Vaccines Market, By Disease 4.4 Veterinary Vaccines Market, By Geography
5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 22.214.171.124 Growth in Livestock Population And Repeated Outbreaks of Livestock Diseases 126.96.36.199 Increasing Adoption of Companion Animals 188.8.131.52 Rising Incidence of Zoonotic Diseases 184.108.40.206 Initiatives By Various Government Agencies, Animal Associations, And Leading Players 220.127.116.11 Introduction of New Types of Vaccines 5.2.2 Restraints 18.104.22.168 High Storage Costs for Vaccines 5.2.3 Opportunities 22.214.171.124 Technological Advancements 126.96.36.199 Growing Awareness of Animal Health in Emerging Economies 5.2.4 Challenge 188.8.131.52 Inadequate Surveillance And Reporting Systems
8 Veterinary Vaccines Market, By Technology 8.1 Introduction 8.2 Live Attenuated Vaccines 8.3 Inactivated Vaccines 8.4 Toxoid Vaccines 8.5 Recombinant Vaccines 8.6 Other Vaccines
9 Veterinary Vaccines Market, By Region 9.1 Introduction 9.2 Europe 9.3 North America 9.3.1 Us 9.3.2 Canada 9.4 Asia Pacific (Apac) 9.4.1 China 9.4.2 Thailand 9.4.3 India 9.4.4 Rest of Apac 9.5 Rest of the World